These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 25805304)
1. Reply to Antinori et al. Miller DA; Traina MM; Meymandi SK Clin Infect Dis; 2015 Jun; 60(12):1875-6. PubMed ID: 25805304 [No Abstract] [Full Text] [Related]
2. Low Incidence of Adverse Effects Using a Progressive Regimen of Benznidazole in Chagas Disease. Navarrete MN; Gutiérrez-Gutiérrez B; de Arellano-Ramos R; Del Castillo SF; Domínguez-Castellano Á Clin Infect Dis; 2016 Apr; 62(8):1052. PubMed ID: 26769725 [No Abstract] [Full Text] [Related]
3. High frequency of adverse reactions and discontinuation with benznidazole treatment for chronic Chagas disease in Milan, Italy. Antinori S; Grande R; Bianco R; Traversi L; Cogliati C; Torzillo D; Repetto E; Corbellino M; Milazzo L; Galli M; Galimberti L Clin Infect Dis; 2015 Jun; 60(12):1873-5. PubMed ID: 25805302 [No Abstract] [Full Text] [Related]
4. Tolerance of benznidazole in a United States Chagas Disease clinic. Miller DA; Hernandez S; Rodriguez De Armas L; Eells SJ; Traina MM; Miller LG; Meymandi SK Clin Infect Dis; 2015 Apr; 60(8):1237-40. PubMed ID: 25601454 [TBL] [Abstract][Full Text] [Related]
5. Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil. Gontijo MKCL; Arruda HMBDS; Noronha EF; Toledo MI Rev Soc Bras Med Trop; 2020; 53():e20190150. PubMed ID: 31994658 [TBL] [Abstract][Full Text] [Related]
6. Adverse systemic reaction to benznidazole. Coronel MV; Frutos LO; Muñoz EC; Valle DK; Rojas DH Rev Soc Bras Med Trop; 2017; 50(1):145-147. PubMed ID: 28327820 [TBL] [Abstract][Full Text] [Related]
7. Adverse events after the use of benznidazole in infants and children with Chagas disease. Altcheh J; Moscatelli G; Moroni S; Garcia-Bournissen F; Freilij H Pediatrics; 2011 Jan; 127(1):e212-8. PubMed ID: 21173000 [TBL] [Abstract][Full Text] [Related]
9. A clinical adverse drug reaction prediction model for patients with chagas disease treated with benznidazole. Sperandio da Silva GM; Mediano MF; Alvarenga Americano do Brasil PE; da Costa Chambela M; da Silva JA; de Sousa AS; Xavier SS; Rodrigues da Costa A; Magalhães Saraiva R; Hasslocher-Moreno AM Antimicrob Agents Chemother; 2014 Nov; 58(11):6371-7. PubMed ID: 25114135 [TBL] [Abstract][Full Text] [Related]
10. [Thioctic acid in the prevention of the toxic effects of benznidazole]. Pérez Lloret A; Roldán EJ Medicina (B Aires); 1984; 44(1):108. PubMed ID: 6443012 [No Abstract] [Full Text] [Related]
11. Should benznidazole be used in chronic Chagas' disease? Bestetti RB Lancet; 1997 Mar; 349(9052):653. PubMed ID: 9057760 [No Abstract] [Full Text] [Related]
12. Arthritis and benznidazole: more closely related than we thought. Aldasoro E; Pinazo MJ; Oliveira I; Munoz J; Posada E; Requena-Méndez A; Serret N; Gascon J Antimicrob Agents Chemother; 2015 Jan; 59(1):727-9. PubMed ID: 25385100 [TBL] [Abstract][Full Text] [Related]